Medical Alley Q1 2023 Venture Report

May 17  

The Medical Alley Venture Report is a quarterly analysis of investment, M&A and other factors driving growth in Medical Alley®, the epicenter of health innovation and care®.

Medical Alley Starts: Venture platform to lower the cost of starting, scaling, and pivoting new ventures.

Medical Alley Global: Bringing Medical Alley to the world and the world to Medical Alley.

The Q1 2023 report includes information on:

  • Medical Alley Starts & Global highlights
  • Private and public markets activity
  • SBIR/STTR funding
  • Job growth in Medical Alley

In Q1 2023, Medical Alley startups raised more than $400 million – $277 million in private capital, $120
million through secondary offerings, and almost $7 million in SBIR/STTR. While the overall numbers are somewhat distorted by a single large private raise, the Medical Alley ecosystem showed resilience in an uncertain market. The increase in SBIR/STTR funding continues to be encouraging.

Digital health and medical device companies were the main drivers in private funding. Biopharma companies recorded a decrease after a record-breaking 2022.

Medical Alley tracked less than half the number of M&A transactions than in any of last year’s quarters, in line with expectations given the broader market slow down. Read the full report by clicking the button below.

Success message!
Warning message!
Error message!